{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T10:04:59Z","timestamp":1790071499295,"version":"4.0.1"},"publisher-location":"New York, NY","reference-count":45,"publisher":"Springer US","isbn-type":[{"value":"9781071655467","type":"print"},{"value":"9781071655474","type":"electronic"}],"license":[{"start":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T00:00:00Z","timestamp":1790121600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T00:00:00Z","timestamp":1790121600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2027]]},"DOI":"10.1007\/978-1-0716-5547-4_18","type":"book-chapter","created":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T09:20:14Z","timestamp":1790068814000},"page":"341-366","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Electroporation for High-Efficiency Delivery of CRISPR to Hematopoietic Cells"],"prefix":"10.1007","author":[{"given":"Nikoletta Y.","family":"Papaioannou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Panayiota L.","family":"Papasavva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petros","family":"Patsali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carsten W.","family":"Lederer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,23]]},"reference":[{"key":"18_CR1","first-page":"e944204","volume":"30","author":"DV Parums","year":"2024","unstructured":"Parums DV (2024) Editorial: First regulatory approvals for CRISPR-Cas9 therapeutic gene editing for sickle cell disease and transfusion-dependent \u03b2-thalassemia. Med Sci Monit Int Med J Exp Clin Res 30:e944204","journal-title":"Med Sci Monit Int Med J Exp Clin Res"},{"key":"18_CR2","doi-asserted-by":"publisher","first-page":"1999","DOI":"10.1182\/blood.2025030137","volume":"147","author":"EA Traxler","year":"2026","unstructured":"Traxler EA, Hotan Q, Shao Y, et al. (2026) An optimized CRISPR-Cas12a genome-wide screen reveals PTPA phosphatase pathway in fetal hemoglobin silencing. Blood 147:1999\u20132010.","journal-title":"Blood"},{"key":"18_CR3","doi-asserted-by":"publisher","first-page":"2201","DOI":"10.1007\/s12033-025-01533-2","volume":"68","author":"A-DH Nguyen","year":"2025","unstructured":"Nguyen A-DH, Quang MT (2025) CRISPR\/Cas9 Genome Editing in Oncology: Mechanisms, Therapeutic Platforms and Translational Challenges. Mol Biotechnol 68:2201\u20132229.","journal-title":"Mol Biotechnol"},{"key":"18_CR4","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1038\/nature03556","volume":"435","author":"FD Urnov","year":"2005","unstructured":"Urnov FD, Miller JC, Lee Y-L et al. (2005) Highly efficient endogenous human gene correction using designed zinc-finger nucleases. Nature 435:646\u2013651","journal-title":"Nature"},{"key":"18_CR5","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1038\/nrm3486","volume":"14","author":"JK Joung","year":"2013","unstructured":"Joung JK, Sander JD (2013) TALENs: a widely applicable technology for targeted genome editing. Nat Rev Mol Cell Biol 14:49\u201355","journal-title":"Nat Rev Mol Cell Biol"},{"key":"18_CR6","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1126\/science.1225829","volume":"337","author":"M Jinek","year":"2012","unstructured":"Jinek M, Chylinski K, Fonfara I et al. (2012) A programmable dual-RNA\u2013guided DNA endonuclease in adaptive bacterial immunity. Science 337:816\u2013821","journal-title":"Science"},{"key":"18_CR7","doi-asserted-by":"publisher","first-page":"1492","DOI":"10.3390\/cells10061492","volume":"10","author":"L Koniali","year":"2021","unstructured":"Koniali L, Lederer CW, Kleanthous M (2021) Therapy development by genome editing of hematopoietic stem cells. Cells 10:1492","journal-title":"Cells"},{"key":"18_CR8","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1038\/nature17946","volume":"533","author":"AC Komor","year":"2016","unstructured":"Komor AC, Kim YB, Packer MS et al. (2016) Programmable editing of a target base in genomic DNA without double-stranded DNA cleavage. Nature 533:420\u2013424","journal-title":"Nature"},{"key":"18_CR9","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1038\/nature24644","volume":"551","author":"NM Gaudelli","year":"2017","unstructured":"Gaudelli NM, Komor AC, Rees HA et al. (2017) Programmable base editing of A\u2022T to G\u2022C in genomic DNA without DNA cleavage. Nature 551:464\u2013471","journal-title":"Nature"},{"key":"18_CR10","doi-asserted-by":"publisher","first-page":"2431","DOI":"10.1038\/s41596-022-00724-4","volume":"17","author":"JL Doman","year":"2022","unstructured":"Doman JL, Sousa AA, Randolph PB et al. (2022) Designing and executing prime editing experiments in mammalian cells. Nat Protoc 17:2431\u20132468","journal-title":"Nat Protoc"},{"key":"18_CR11","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1186\/s13059-026-03974-7","volume":"27","author":"NY Papaioannou","year":"2026","unstructured":"Papaioannou NY, Patsali P, Klermund J, et al. (2026) Functional correction and genome integrity with duplex base editing of \u03b2-thalassemic hematopoietic stem cells. Genome Biol 27:67.","journal-title":"Genome Biol"},{"key":"18_CR12","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1182\/blood.2022016629","volume":"141","author":"G Hardouin","year":"2023","unstructured":"Hardouin G, Antoniou P, Martinucci P et al. (2023) Adenine base editor-mediated correction of the common and severe IVS1-110 (G>A) \u03b2-thalassemia mutation. Blood 141:1169\u20131179","journal-title":"Blood"},{"key":"18_CR13","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-34493-1","volume":"13","author":"P Antoniou","year":"2022","unstructured":"Antoniou P, Hardouin G, Martinucci P et al. (2022) Base-editing-mediated dissection of a \u03b3-globin cis-regulatory element for the therapeutic reactivation of fetal hemoglobin expression. Nat Commun 13: 6618","journal-title":"Nat Commun"},{"key":"18_CR14","doi-asserted-by":"publisher","first-page":"1540","DOI":"10.1182\/blood.2020010020","volume":"138","author":"N Psatha","year":"2021","unstructured":"Psatha N, Georgakopoulou A, Li C et al. (2021) Enhanced HbF reactivation by multiplex mutagenesis of thalassemic CD34+ cells in vitro and in vivo. Blood 138:1540\u20131553","journal-title":"Blood"},{"key":"18_CR15","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1016\/j.stem.2017.10.010","volume":"21","author":"RA Morgan","year":"2017","unstructured":"Morgan RA, Gray D, Lomova A et al. (2017) Hematopoietic stem cell gene therapy: progress and lessons learned. Cell Stem Cell 21:574\u2013590","journal-title":"Cell Stem Cell"},{"key":"18_CR16","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1186\/s13287-024-03848-4","volume":"15","author":"Z Molaei","year":"2024","unstructured":"Molaei Z, Jabbarpour Z, Omidkhoda A et al. (2024) Exploring non-viral methods for the delivery of CRISPR-Cas ribonucleoprotein to hematopoietic stem cells. Stem Cell Res Ther 15:233","journal-title":"Stem Cell Res Ther"},{"key":"18_CR17","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1038\/nbt.3290","volume":"33","author":"A Hendel","year":"2015","unstructured":"Hendel A, Bak RO, Clark JT et al. (2015) Chemically modified guide RNAs enhance CRISPR-Cas genome editing in human primary cells. Nat Biotechnol 33:985\u2013989","journal-title":"Nat Biotechnol"},{"key":"18_CR18","doi-asserted-by":"publisher","DOI":"10.1186\/1472-6750-10-9","volume":"10","author":"R Maurisse","year":"2010","unstructured":"Maurisse R, De Semir D, Emamekhoo H et al. (2010) Comparative transfection of DNA into primary and transformed mammalian cells from different lineages. BMC Biotechnol 10: 9","journal-title":"BMC Biotechnol"},{"key":"18_CR19","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1182\/blood.V98.1.49","volume":"98","author":"VF Van Tendeloo","year":"2001","unstructured":"Van Tendeloo VF, Ponsaerts P, Lardon F et al. (2001) Highly efficient gene delivery by mRNA electroporation in human hematopoietic cells: superiority to lipofection and passive pulsing of mRNA and to electroporation of plasmid cDNA for tumor antigen loading of dendritic cells. Blood 98:49\u201356","journal-title":"Blood"},{"key":"18_CR20","doi-asserted-by":"publisher","first-page":"3044","DOI":"10.3390\/molecules23113044","volume":"23","author":"J Shi","year":"2018","unstructured":"Shi J, Ma Y, Zhu J et al. (2018) A review on electroporation-based intracellular delivery. Molecules 23:3044","journal-title":"Molecules"},{"key":"18_CR21","doi-asserted-by":"crossref","unstructured":"Rolong A, Davalos RV, Rubinsky B (2018) History of electroporation. In: Meijerink MR, Scheffer HJ, Narayanan G (eds) Irreversible electroporation in clinical practice. Springer International Publishing, Cham. pp 13\u201337","DOI":"10.1007\/978-3-319-55113-5_2"},{"key":"18_CR22","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1002\/j.1460-2075.1982.tb01257.x","volume":"1","author":"E Neumann","year":"1982","unstructured":"Neumann E, Schaefer-Ridder M, Wang Y et al. (1982) Gene transfer into mouse lyoma cells by electroporation in high electric fields. EMBO J 1:841\u2013845","journal-title":"EMBO J"},{"key":"18_CR23","doi-asserted-by":"publisher","first-page":"7161","DOI":"10.1073\/pnas.81.22.7161","volume":"81","author":"H Potter","year":"1984","unstructured":"Potter H, Weir L, Leder P (1984) Enhancer-dependent expression of human kappa immunoglobulin genes introduced into mouse pre-B lymphocytes by electroporation. Proc Natl Acad Sci USA 81:7161\u20137165","journal-title":"Proc Natl Acad Sci USA"},{"key":"18_CR24","doi-asserted-by":"publisher","first-page":"102457","DOI":"10.1016\/j.omtn.2025.102457","volume":"36","author":"A Cavazza","year":"2025","unstructured":"Cavazza A, Molina-Est\u00e9vez FJ, Reyes \u00c1P et al. (2025) Advanced delivery systems for gene editing: a comprehensive review from the GenE-HumDi COST Action Working Group. Mol Ther Nucleic Acids 36:102457","journal-title":"Mol Ther Nucleic Acids"},{"key":"18_CR25","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1089\/hum.2016.107","volume":"27","author":"K-R Yu","year":"2016","unstructured":"Yu K-R, Natanson H, Dunbar CE (2016) Gene editing of human hematopoietic stem and progenitor cells: promise and potential hurdles. Hum Gene Ther 27:729\u2013740","journal-title":"Hum Gene Ther"},{"key":"18_CR26","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.ymthe.2018.10.008","volume":"27","author":"A Lattanzi","year":"2019","unstructured":"Lattanzi A, Meneghini V, Pavani G et al. (2019) Optimization of CRISPR\/Cas9 delivery to human hematopoietic stem and progenitor cells for therapeutic genomic rearrangements. Mol Ther 27:137\u2013150","journal-title":"Mol Ther"},{"key":"18_CR27","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.1101\/gr.171322.113","volume":"24","author":"S Kim","year":"2014","unstructured":"Kim S, Kim D, Cho SW et al. (2014) Highly efficient RNA-guided genome editing in human cells via delivery of purified Cas9 ribonucleoproteins. Genome Res 24:1012\u20131019","journal-title":"Genome Res"},{"key":"18_CR28","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/j.tibtech.2017.11.006","volume":"36","author":"Z Glass","year":"2018","unstructured":"Glass Z, Lee M, Li Y et al. (2018) Engineering the delivery system for CRISPR-based genome editing. Trends Biotechnol 36:173\u2013185","journal-title":"Trends Biotechnol"},{"key":"18_CR29","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/j.biomaterials.2017.11.034","volume":"156","author":"H Kwon","year":"2018","unstructured":"Kwon H, Kim M, Seo Y et al. (2018) Emergence of synthetic mRNA: In vitro synthesis of mRNA and its applications in regenerative medicine. Biomaterials 156:172\u2013193","journal-title":"Biomaterials"},{"key":"18_CR30","doi-asserted-by":"publisher","DOI":"10.3389\/fgeed.2023.1141618","volume":"5","author":"NY Papaioannou","year":"2023","unstructured":"Papaioannou NY, Patsali P, Naiisseh B, et al. (2023) High-efficiency editing in hematopoietic stem cells and the HUDEP-2 cell line based on in vitro mRNA synthesis. Front Genome Ed 5, 1141618.","journal-title":"Front Genome Ed"},{"key":"18_CR31","unstructured":"Lonza. (n.d.). Electroporation and Nucleofector\u00ae Technology. https:\/\/bioscience.lonza.com\/nucleofector-technology"},{"key":"18_CR32","unstructured":"Kluesner, M.G. (2018). EditR\u2014estimating base editing by Sanger sequencing, http:\/\/baseeditr.com\/"},{"key":"18_CR33","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1089\/crispr.2018.0014","volume":"1","author":"MG Kluesner","year":"2018","unstructured":"Kluesner MG, Nedveck DA, Lahr WS, et al. (2018) EditR: a method to quantify base editing from Sanger Sequencing. CRISPR J 1:239\u2013250.","journal-title":"CRISPR J"},{"key":"18_CR34","unstructured":"Synthego (2018). How to use ice: a detailed guide for analyzing CRISPR editing results. https:\/\/www.synthego.com\/guide\/how-to-use-crispr\/ice-analysis-guide\/"},{"key":"18_CR35","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1089\/crispr.2021.0113","volume":"5","author":"D Conant","year":"2022","unstructured":"Conant D, Hsiau T, Rossi N et al. (2022) Inference of CRISPR edits from Sanger trace data. CRISPR J 5:123\u2013130","journal-title":"CRISPR J"},{"key":"18_CR36","doi-asserted-by":"publisher","first-page":"2182","DOI":"10.1182\/blood.V80.9.2182.2182","volume":"80","author":"JS Miller","year":"1992","unstructured":"Miller JS, Verfaillie C, McGlave P (1992) The generation of human natural killer cells from CD34+\/DR- primitive progenitors in long-term bone marrow culture. Blood 80:2182\u20132187","journal-title":"Blood"},{"key":"18_CR37","unstructured":"Clinton J, Shapiro B (2015) Differentiation and expansion of hematopoietic precursor cells from bone-marrow derived CD34+ progenitors. ATCC Resour Appl Notes. ATCC"},{"key":"18_CR38","doi-asserted-by":"publisher","first-page":"3532","DOI":"10.1182\/blood.V114.22.3532.3532","volume":"114","author":"C Reimann","year":"2009","unstructured":"Reimann C, Dal-Cortivo L, Ternaux B et al. (2009) In vitro generation of human T-cell precursors from bone marrow CD34+ cells by short exposure to immobilized Notch-ligand delta-like 4. Blood 114:3532","journal-title":"Blood"},{"key":"18_CR39","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.jim.2010.06.002","volume":"359","author":"M Ichii","year":"2010","unstructured":"Ichii M, Oritani K, Yokota T et al. (2010) Stromal cell-free conditions favorable for human B lymphopoiesis in culture. J Immunol Methods 359:47\u201355","journal-title":"J Immunol Methods"},{"key":"18_CR40","doi-asserted-by":"publisher","first-page":"7291","DOI":"10.1158\/0008-5472.CAN-11-1715","volume":"71","author":"TG Sommermann","year":"2011","unstructured":"Sommermann TG, O\u2019Neill K, Plas DR et al. (2011) IKK\u03b2 and NF-\u03baB transcription govern lymphoma cell survival through AKT-induced plasma membrane trafficking of GLUT1. Cancer Res 71:7291\u20137300","journal-title":"Cancer Res"},{"key":"18_CR41","first-page":"99","volume":"4","author":"L Chicaybam","year":"2016","unstructured":"Chicaybam L, Barcelos C, Peixoto B et al. (2016) An efficient electroporation protocol for the genetic modification of mammalian cells. Front Bioeng Biotechnol 4:99","journal-title":"Front Bioeng Biotechnol"},{"key":"18_CR42","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1016\/j.celrep.2017.06.064","volume":"20","author":"RO Bak","year":"2017","unstructured":"Bak RO, Porteus MH (2017) CRISPR-mediated integration of large gene cassettes using AAV donor vectors. Cell Rep 20:750\u2013756","journal-title":"Cell Rep"},{"key":"18_CR43","doi-asserted-by":"publisher","DOI":"10.17504\/protocols.io.64qhgvw","author":"E Danner","year":"2019","unstructured":"Danner E (2019) Lonza 4D nucleofection with effective homemade buffer (here using K562 with Cas9 plasmid). Protocols.io https:\/\/doi.org\/10.17504\/protocols.io.64qhgvw","journal-title":"Protocols.io"},{"key":"18_CR44","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1534\/g3.114.015834","volume":"5","author":"L Vouillot","year":"2015","unstructured":"Vouillot L, Th\u00e9lie A, Pollet N (2015) Comparison of T7E1 and surveyor mismatch cleavage assays to detect mutations triggered by engineered nucleases. G3 5:407\u2013415","journal-title":"G3"},{"key":"18_CR45","doi-asserted-by":"publisher","first-page":"e497","DOI":"10.3324\/haematol.2018.215178","volume":"104","author":"P Patsali","year":"2019","unstructured":"Patsali P, Turchiano G, Papasavva P, et al. (2019) Correction of IVS I-110(GA) \u03b2-thalassemia by CRISPR\/Cas-and TALEN-mediated disruption of aberrant regulatory elements in human hematopoietic stem and progenitor cells. Haematologica 104:e497\u2013e501","journal-title":"Haematologica"}],"container-title":["Methods in Molecular Biology","CRISPR Delivery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-1-0716-5547-4_18","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T09:20:21Z","timestamp":1790068821000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-1-0716-5547-4_18"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,23]]},"ISBN":["9781071655467","9781071655474"],"references-count":45,"URL":"https:\/\/doi.org\/10.1007\/978-1-0716-5547-4_18","relation":{},"ISSN":["1064-3745","1940-6029"],"issn-type":[{"value":"1064-3745","type":"print"},{"value":"1940-6029","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,23]]},"assertion":[{"value":"23 September 2026","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}},{"value":"The authors have no conflicts of interest to declare that are relevant to the content of this chapter.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}